Treatment options for CAP in patients with comorbidities such as chronic heart, lung, liver, or renal disease; diabetes mellitus; alcoholism; malignancy; asplenia; immunosuppression; prior antibiotics within 90 days; or other risk factors for drug-resistant infection include the following: Beta-lactam...
Malignancy is reported in 1.7% of patients. We wanted to assess how this was organised across our trust and the outcomes, aiming to improve organisation of the service. Methods Patients were identified via retrospective review of local NIV/COPD and critical care ICNARC databases. Xrays and ...
Women with a hysterectomy: if the cervix is removed, and there is no evidence of malignancy and no history of abnormal cancerous cell growth, Pap smears can be discontinued. • If there is a previous history of abnormal cervical cell growth, annual screening is recommended until there are ...
The elderly patient with malignancy is often considered a poor risk for treatment. To assess the effect of age on the treatment of one such disease, multip... Dr.,HARVEY,JAY,... - 《Journal of the American Geriatrics Society》 被引量: 43发表: 1983年 Efficacy and Toxicosis of VELCAP-C...
more than 99% probability of thyroid cancer, and it serves as a marker of aggressive behavior.1 Preoperatively detected BRAF-positive nodules should be extensively excised,18 with more aggressive treatment and follow-up.19 Detection of a RAS mutation in FNA samples correlates with malignancy in ...
Efficacy and safety of apatinib in patients with recurrent uterine malignancy: a prospective, single-center, single-arm, phase 2 study. Ann Transl Med. 2023;11(2):106. Article CAS PubMed PubMed Central Google Scholar Qin S, Ren Z, Meng Z, Chen Z, Chai X, Xiong J, Bai Y, Yang L...
The association of all-cause mortality with most of the evaluated chronic comorbidities, and especially with malignancy and chronic neurologic disease, is in line with previous literature [25], [31]. This underscores the importance of careful evaluation of chronic comorbidities in every patient with ...
June 2018—With core needle biopsies of the breast, if something looks like an epithelial malignancy, ask yourself: Is it really a carcinoma? If it is a carcinoma, ask yourself if it is a primary breast carcinoma. Read More » LCIS variants and DCIS: tips on telling them apart ...
18 with more aggressive treatment and follow-up.19 Detection of a RAS mutation in FNA samples correlates with malignancy in 74% to 88% of cases,20,21 and it is a useful marker for pre operative diagnosis of follicular variant of papillary carcinoma and follicular carcinoma, both of which ...
Other active, invasive malignancy requiring ongoing therapy or expected to require systemic therapy within two years. Localized squamous cell carcinoma of the skin, basal-cell carcinoma of the skin, carcinoma in-situ of the cervix, or other malignancies requiring locally ablative therapy only ...